Every baby born that enters this world, arrives with an umbilical cord in tow. For those babies born addicted to drugs, that umbilical cord is now a key connection—a hard to hide clue—for identifying what drugs are coursing through a newborn’s veins. The drug(s) detected will help physicians determine the best treatment and what withdrawal symptoms to expect.
“There is no cure for HHT, yet if we can find new genetic modifiers or new genes, then we can potentially find novel therapeutics to treat these patients,” explains an enthusiastic Whitney Wooderchak-Donahue, PhD, a researcher with the University of Utah and ARUP Laboratories. Last week, she received the 2015 Young Scholar Research Grant ($30,000) for her research proposal that involves focusing on patients’ transcripts (the RNA in the cell) via their blood samples to identify genetic modifiers in Hereditary Hemorrhagic Telangiectasia (HHT).
Asahi Kasei Fibers has begun commercial production and supply of NanoAct™ cellulose nanobeads, and is now accelerating the development of lateral flow immunoassays in Japan and worldwide.
Remember when the doctor came to your house? Well, your grandmother does. Now doctors are coming to the workplace. Not only is it convenient for employees—saving time and keeping them nearby—but, executives are seeing company savings in a time of rising healthcare costs.
As thousands turn out this spring to run and walk in memory of loved ones lost to breast cancer, behind-the-scene researchers are running a race of a different kind to help physicians treat their cancer patients. It is a race to acquire genetic knowledge, and success is dependent on collaborations and expertise from researchers worldwide.
Beckman Coulter Diagnostics has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Access 25(OH) Vitamin D Total assay. Offering state-of-the-art performance, the new assay is an important addition to the company’s bone metabolism assay menu and is available for use on its Access 2 and UniCel DxI series of immunoassay systems.
DRG International, a leading international medical diagnostic company, will showcase the NEW DRG® Hepcidin 25 (bioactive) HS (High Sensitive) ELISA Kit (EIA-5782) at the 2015 AACC in Atlanta, Georgia from July 27-30. As the first of its kind to market, this kit accurately detects bioactive Hepcidin levels as an additional marker to aid in identifying a variety of disorders. In recent years, a large number of publications identify Hepcidin as a factor in regulating the amount of iron in humans. Unbalanced iron level can lead to many common medical conditions including anemia and iron overload disease, and can occur in chronic kidney disease, inflammation, or diabetes mellitus
Our main products are: automated immunoassay workstation ( Elisa & Clia series ); automated liquid handlig platform; OEM and custom development series.
Following the commercial launch of Seralite® - FLC Abingdon Health is looking to appoint distributors in order to enable as many people as possible affected by multiple myeloma (a cancer arising from plasma cells) to have access to, and benefit from its rapid diagnostic capabilities.
The Lee Company’s new LPG Series Inert Solenoid Pump was designed to offer greater design flexibility and significant cost savings to the medical and scientific industries.
Overdoses of opioid pain medications frequently occur in people who aren't chronic users with high prescribed opioid doses—the groups targeted by current opioid prescribing guidelines, reports a study in the August issue of Medical Care. The journal is published by Wolters Kluwer.
33% of students who used bath salts reported using only once or twice; however, frequent use was also common among users with an alarming 18% of users reporting using 40 or more times in the last year.
For people who use cocaine, stopping or reducing cocaine use is associated with decreased levels of endothelin-1 (ET-1)—a protein that plays a key role in the development of coronary artery disease, reports a study in the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine. The journal is published by Wolters Kluwer.
In a nationwide study, researchers from the University of Georgia School of Social Work found that individuals of any age who used illicit drugs such as marijuana, cocaine or heroin within the past year had a higher likelihood of misusing prescription pain relievers as well.
A study published in the Online First edition of Anesthesiology, the official medical journal of the American Society of Anesthesiologists® (ASA®), found patients who were prescribed opioids to treat chronic lower back pain experienced significantly less pain relief and were more likely to abuse their medication when they had psychiatric disorders.
Other topics include neurology, obesity, statins, and the risks of wearing high heels.
While most Americans do not support policies designed to increase distribution of naloxone – a medication that reverses the effects of a drug overdose – certain types of educational messages about its lifesaving benefits may bolster support for its use, new Johns Hopkins Bloomberg School of Public Health research suggests.
Other topics include; do x-rays really cause cancer? And more.
Despite concerns that use of antipsychotic medications in treating young people has increased, use actually declined between 2006 and 2010 for children ages 12 and under, and increased for adolescents and young adults.
The need for psychiatric services in inpatient hospitals continues to grow, according to the latest annual survey from the National Association of Psychiatric Health Systems (NAPHS).
People with blue eyes might have a greater chance of becoming alcoholics, according to a unique new study by genetic researchers at the University of Vermont.
While cannabis alters the functions of neurobiological circuits controlling appetite, its effect on weight gain is complex since several factors appear to be involved, says Didier Jutras-Aswad, University of Montreal professor and researcher at the CHUM Research Centre.
Other topics include weight loss, medical marijuana, smart traffic lights, diabetes, heart disease, and more.
Smokeless tobacco and, more recently, e-cigarettes have been promoted as a harm reduction strategy for smokers who are “unable or unwilling to quit.” The strategy, embraced by both industry and some public health advocates, is based on the assumption that as smoking declines overall, only those who cannot quit will remain. A new study by researchers at UC San Francisco has found just the opposite.
Many primary care physicians – the top prescribers of prescription pain pills in the United States – don’t understand basic facts about how people may abuse the drugs or how addictive different formulations of the medications can be, new Johns Hopkins Bloomberg School of Public Health research suggests.
Topics include: women's health, cancer care, research at the Large Hadron Collider, dementia drug treatment, dermatology, skin cancer, breast cancer, smoking risks, and genetics.
The Diatron Group,a global provider of hematology and clinical chemistry analyzers, will display its new economic walk-away clinical chemistry analyzer, the Pictus P500, at the AACC, Atlanta (28-30 July 2015), on booth No 2100.
Topics include: treating advanced skin cancer, big data and bioenergy, cancer research, 10 reasons to eat quinoa, sleep issues in the nursing field, advances in cancer surgery, genes for sleep, brain receptor for cocaine addiction, and nano imaging on insect adaptations.
New research offers further evidence that cocaine use disrupts the immune system, making people who use it more likely to become infected with HIV.
You can whack it with a hammer, attack it with a drill, or even stab it with a screwdriver. But try as you might, you won’t be able to get into this pill dispenser. Which is exactly the idea.
By manipulating the activity of Activin receptors in the brain, researchers were able to increase or decrease cocaine-taking and relapse behavior in animal models. The study focused on receptors in regions of the brain involved in pleasure and reward.
Despite stereotypes about college students resorting to black-market Ritalin to help them cram for exams, young people are actually most likely to start misusing prescription stimulant drugs in their high school years, according to new University of Michigan Medical School research.
Expert can speak on the need for treatment of pain with less potential for abuse than existing painkillers; for better options for those already dealing with opioid dependence; and for the need to address patients’ lifestyles as well as bodies to ensure optimal treatment. Dr. Mark Sirgo is president and CEO of BioDelivery Sciences, whose FDA-approved drug BUNAVAIL and investigational drug BELBUCA allow for the efficient delivery of buprenorphine while potentially overcoming some of the administration challenges presented by sublingual dosage forms, and whose Inreach Assist website and app offers a comprehensive array of information and resources to support patients dealing with addiction and their families.
Contrary to some popular beliefs, marijuana is harmful to adolescent brains. Researchers have found that targeting at-risk youth through school programmes can limit their use of this drug.
As more infants are born to mothers with dependence on prescription pain medications, the costs of treatment for babies with neonatal abstinence syndrome (NAS) have increased dramatically, suggests a report in the March/April issue of the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine. The journal is published by Wolters Kluwer.
Trending news releases with the most views in a single day. Topics include: nutrition, fibromyalgia, e-cigarettes, cystic fibrosis, asthma, and gluten
Four different financial incentive programs, each worth roughly $800 over six months, all help more smokers kick the habit than providing free access to behavioral counseling and nicotine replacement therapy. Further, the way in which equally-sized payouts are structured influences their effectiveness. The findings are the result of a year-long randomized trial among CVS Caremark (now CVS Health) employees that was conducted by researchers at the University of Pennsylvania.
Smokers who are able to quit might actually be hard-wired for success, according to a study from Duke Medicine. The study, published in Neuropsychopharmacology, showed greater connectivity among certain brain regions in people who successfully quit smoking compared to those who tried and failed.
The world’s first comprehensive report on global addictions has revealed Australians smoke less tobacco and drink less alcohol than the British, but Aussies take more illicit drugs.
Scientists at The Scripps Research Institute have discovered that a brain protein has a key role in controlling binge drinking in animal models.
Scientists at The Scripps Research Institute have found using animal models that the new recreational drug alpha-PVP (“flakka”) seems equivalently potent as a stimulant, and therefore as addictive, as its chemical cousin MDPV (“bath salts”).
The number of infants born in the United States with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), nearly doubled in a four-year period. By 2012, one infant was born every 25 minutes in the U.S. with the syndrome, accounting for $1.5 billion in annual health care charges, according to a new Vanderbilt study published in the Journal of Perinatology.
An increasing number of babies across the country are born addicted to opioids and require intensive care, according to a study analyzing MEDNAX Clinical Data Warehouse statistics from 299 neonatal intensive care units (NICUs) around the United States.
Inspired by a half century’s worth of big tobacco research around the taste of nicotine, a smoking cessation scientist is working to understand how a person’s taste perception might make them a better or worse candidate for oral nicotine replacement therapy.
Trending news releases with the most views in a single day. Topics include: neurology, environment, crowdfunding, engineering, smoking, pharmaceuticals, medical research, cardiology and diabetes
Trending news releases with the most views in a single day. Topics include: robotics, nicotine and alcohol, stem cells, vision, cancer, pregnancy, racial disparities in smoking risk, and herbal therapy for cardiac hypertrophy
A study led by scientists at The Scripps Research Institute reveals that, in rat models, nicotine exposure actually promotes alcohol dependence.
It has been called a pioneering strategy for treating opioid addiction, and has already been adopted in a small yet growing number of jails and prisons in the United States. Now, a clinical trial published in the journal Addiction by researchers at NYU Langone Medical Center finds that the extended-release medication naltrexone (XR-NTX) is associated with a significant decline in relapse rates for a group of mostly heroin-dependent men after their release from New York City jails.
April is National Minority Health Month, and one of the most significant health issues minorities face is disproportionate rates of smoking and health-related illnesses. At NYC Treats Tobacco, we are committed to ending health disparities. We have physician experts available to speak about these issues.
Trending news releases with the most views in a single day. Topics include: organic chemistry, cybercrime, pancreatic cancer research from Mayo Clinic, diabetes, pediatrics, new cancer treatment in development at Beth Israel Deaconess Medical Center, pain medicine research from the Ohio State University, marijuana in the workplace, and stem cells
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right